SARS-CoV-2 infection in a pediatric patient with cystic fibrosis

Abstract Background: Cystic fibrosis (CF) is a potentially mortal disease characterized by a chronic pulmonary disease with persistent airway infection. Children with this disease are more susceptible to respiratory infections due to the limitation in mucociliary transport and anatomical disruption of the bronchial tree. SARS-CoV-2 causes COVID-19, a respiratory illness related to exacerbations of chronic pulmonary pathologies in children, such as CF and asthma. There are not enough case reports on pediatric patients with SARS-CoV-2 infection and CF, for which we share our experience. Case report: A 22-month-old male patient diagnosed with CF presented in the hospital with cough, fever, and increased respiratory work. The patient received supplemental oxygen and antibiotic and antiviral therapy. Positive results for type B influenza and RT-PCR (reverse transcription-polymerase chain reaction) for SARS-CoV-2 were obtained. Due to the persistence of respiratory difficulty, high-flow therapy was initiated, with a good response. After an episode of hypoxemia, bradycardia, and increased respiratory work secondary to accumulated secretions, orotracheal intubation and invasive mechanical ventilation were performed. The patient evolved with clinical and gasometric improvement. After 10 days of in-hospital antibiotic management with adequate clinical evolution, the patient was discharged to complete oral treatment and home isolation. Conclusions: We present a case of chronic respiratory disease and SARS-CoV-2 infection with severity criteria in a pediatric patient. The evolution was favorable with timely support management and antibiotic therapy in a third-level hospital.

Saved in:
Bibliographic Details
Main Authors: Páez-Velásquez,Jackelyn S., Romero-Uribe,Ilse E., Castilla-Peón,María F., Lezana-Fernández,José L., Chávez-López,Adrián
Format: Digital revista
Language:English
Published: Instituto Nacional de Salud, Hospital Infantil de México Federico Gómez 2021
Online Access:http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1665-11462021000100029
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1665-11462021000100029
record_format ojs
spelling oai:scielo:S1665-114620210001000292021-03-24SARS-CoV-2 infection in a pediatric patient with cystic fibrosisPáez-Velásquez,Jackelyn S.Romero-Uribe,Ilse E.Castilla-Peón,María F.Lezana-Fernández,José L.Chávez-López,Adrián COVID-19 SARS-CoV-2 Coronavirus Cystic fibrosis Abstract Background: Cystic fibrosis (CF) is a potentially mortal disease characterized by a chronic pulmonary disease with persistent airway infection. Children with this disease are more susceptible to respiratory infections due to the limitation in mucociliary transport and anatomical disruption of the bronchial tree. SARS-CoV-2 causes COVID-19, a respiratory illness related to exacerbations of chronic pulmonary pathologies in children, such as CF and asthma. There are not enough case reports on pediatric patients with SARS-CoV-2 infection and CF, for which we share our experience. Case report: A 22-month-old male patient diagnosed with CF presented in the hospital with cough, fever, and increased respiratory work. The patient received supplemental oxygen and antibiotic and antiviral therapy. Positive results for type B influenza and RT-PCR (reverse transcription-polymerase chain reaction) for SARS-CoV-2 were obtained. Due to the persistence of respiratory difficulty, high-flow therapy was initiated, with a good response. After an episode of hypoxemia, bradycardia, and increased respiratory work secondary to accumulated secretions, orotracheal intubation and invasive mechanical ventilation were performed. The patient evolved with clinical and gasometric improvement. After 10 days of in-hospital antibiotic management with adequate clinical evolution, the patient was discharged to complete oral treatment and home isolation. Conclusions: We present a case of chronic respiratory disease and SARS-CoV-2 infection with severity criteria in a pediatric patient. The evolution was favorable with timely support management and antibiotic therapy in a third-level hospital.info:eu-repo/semantics/openAccessInstituto Nacional de Salud, Hospital Infantil de México Federico GómezBoletín médico del Hospital Infantil de México v.78 n.1 20212021-02-01info:eu-repo/semantics/reporttext/htmlhttp://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1665-11462021000100029en10.24875/bmhim.20000216
institution SCIELO
collection OJS
country México
countrycode MX
component Revista
access En linea
databasecode rev-scielo-mx
tag revista
region America del Norte
libraryname SciELO
language English
format Digital
author Páez-Velásquez,Jackelyn S.
Romero-Uribe,Ilse E.
Castilla-Peón,María F.
Lezana-Fernández,José L.
Chávez-López,Adrián
spellingShingle Páez-Velásquez,Jackelyn S.
Romero-Uribe,Ilse E.
Castilla-Peón,María F.
Lezana-Fernández,José L.
Chávez-López,Adrián
SARS-CoV-2 infection in a pediatric patient with cystic fibrosis
author_facet Páez-Velásquez,Jackelyn S.
Romero-Uribe,Ilse E.
Castilla-Peón,María F.
Lezana-Fernández,José L.
Chávez-López,Adrián
author_sort Páez-Velásquez,Jackelyn S.
title SARS-CoV-2 infection in a pediatric patient with cystic fibrosis
title_short SARS-CoV-2 infection in a pediatric patient with cystic fibrosis
title_full SARS-CoV-2 infection in a pediatric patient with cystic fibrosis
title_fullStr SARS-CoV-2 infection in a pediatric patient with cystic fibrosis
title_full_unstemmed SARS-CoV-2 infection in a pediatric patient with cystic fibrosis
title_sort sars-cov-2 infection in a pediatric patient with cystic fibrosis
description Abstract Background: Cystic fibrosis (CF) is a potentially mortal disease characterized by a chronic pulmonary disease with persistent airway infection. Children with this disease are more susceptible to respiratory infections due to the limitation in mucociliary transport and anatomical disruption of the bronchial tree. SARS-CoV-2 causes COVID-19, a respiratory illness related to exacerbations of chronic pulmonary pathologies in children, such as CF and asthma. There are not enough case reports on pediatric patients with SARS-CoV-2 infection and CF, for which we share our experience. Case report: A 22-month-old male patient diagnosed with CF presented in the hospital with cough, fever, and increased respiratory work. The patient received supplemental oxygen and antibiotic and antiviral therapy. Positive results for type B influenza and RT-PCR (reverse transcription-polymerase chain reaction) for SARS-CoV-2 were obtained. Due to the persistence of respiratory difficulty, high-flow therapy was initiated, with a good response. After an episode of hypoxemia, bradycardia, and increased respiratory work secondary to accumulated secretions, orotracheal intubation and invasive mechanical ventilation were performed. The patient evolved with clinical and gasometric improvement. After 10 days of in-hospital antibiotic management with adequate clinical evolution, the patient was discharged to complete oral treatment and home isolation. Conclusions: We present a case of chronic respiratory disease and SARS-CoV-2 infection with severity criteria in a pediatric patient. The evolution was favorable with timely support management and antibiotic therapy in a third-level hospital.
publisher Instituto Nacional de Salud, Hospital Infantil de México Federico Gómez
publishDate 2021
url http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1665-11462021000100029
work_keys_str_mv AT paezvelasquezjackelyns sarscov2infectioninapediatricpatientwithcysticfibrosis
AT romerouribeilsee sarscov2infectioninapediatricpatientwithcysticfibrosis
AT castillapeonmariaf sarscov2infectioninapediatricpatientwithcysticfibrosis
AT lezanafernandezjosel sarscov2infectioninapediatricpatientwithcysticfibrosis
AT chavezlopezadrian sarscov2infectioninapediatricpatientwithcysticfibrosis
_version_ 1756227137903263744